Last reviewed · How we verify
testosterone undecanoate plus dutasteride
At a glance
| Generic name | testosterone undecanoate plus dutasteride |
|---|---|
| Also known as | Nebid, Avodart |
| Sponsor | Unita Complessa di Ostetricia e Ginecologia |
| Modality | Small molecule |
| Phase | Phase 3 |
Approved indications
Common side effects
Key clinical trials
- Effects of Testosterone Plus Dutasteride or Placebo on Muscle Strength, Body Composition and Metabolism in Transmen (PHASE3)
- Testosterone and Its Metabolites in GID (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: